Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with CKD Read more
Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer Read more
Boehringer and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies Read more
Takeda Submits NDA for a Subcutaneous Formulation of Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis in Japan Read more
Pfizer Announces Closing of Joint Venture With GlaxoSmithKline to Create a Premier Global Consumer Healthcare Company Read more
Novartis Kisqali significantly prolongs life in women with HR+/HER2- advanced breast cancer now in two distinct Phase III trials Read more
Baxter Announces FDA Approval of Myxredlin, the First and Only Ready-To-Use Insulin for IV Infusion Read more
Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis Read more